TTM
$8.03B
YoY change
+5.8%
5Y CAGR
+0.5%
Peak year (2021)
$10.32B
Cumulative operating income
$84.10B
Operating Income history chart for Thermo Fisher Scientific (TMO) from 1985 to 2025
Latest: $8.11B
Operating Income growth chart for Thermo Fisher Scientific (TMO) from 1985 to 2025
Latest: +5.8%
Operating Income history table for Thermo Fisher Scientific (TMO) from 1985 to 2025
| 2025 | $8.11B | +5.8% | +$447.00M | ||
| 2024 | $7.66B | +2.9% | +$216.00M | ||
| 2023 | $7.45B | -12.7% | −$1.08B | ||
| 2022 | $8.53B | -17.4% | −$1.79B | ||
| 2021 | $10.32B | +30.7% | +$2.42B | ||
| 2020 | $7.90B | +85.4% | +$3.64B | ||
| 2019 | $4.26B | +10.0% | +$387.00M | ||
| 2018 | $3.87B | +18.5% | +$605.00M | ||
| 2017 | $3.27B | +14.3% | +$408.10M | ||
| 2016 | $2.86B | +14.6% | +$364.40M | ||
| 2015 | $2.49B | +6.2% | +$146.10M | ||
| 2014 | $2.35B | +30.6% | +$549.70M | ||
| 2013 | $1.80B | +10.4% | +$169.40M | ||
| 2012 | $1.63B | +10.0% | +$147.90M | ||
| 2011 | $1.48B | +17.2% | +$216.90M | ||
| 2010 | $1.26B | +13.1% | +$146.60M | ||
| 2009 | $1.12B | -11.7% | −$148.40M | ||
| 2008 | $1.27B | +18.8% | +$200.50M | ||
| 2007 | $1.07B | +191.8% | +$700.50M | ||
| 2006 | $365.30M | +24.3% | +$71.52M | ||
| 2005 | $293.77M | +15.5% | +$39.33M | ||
| 2004 | $254.44M | +37.7% | +$69.67M | ||
| 2003 | $184.77M | +18.9% | +$29.32M | ||
| 2002 | $155.45M | +354.5% | +$121.25M | ||
| 2001 | $34.20M | -82.7% | −$163.96M | ||
| 2000 | $198.16M | -20.3% | −$50.44M | ||
| 1999 | $248.60M | -33.8% | −$127.20M | ||
| 1998 | $375.80M | -7.7% | −$31.20M | ||
| 1997 | $407.00M | +43.2% | +$122.80M | ||
| 1996 | $284.20M | +14.9% | +$36.90M | ||
| 1995 | $247.30M | +37.5% | +$67.50M | ||
| 1994 | $179.80M | +45.5% | +$56.20M | ||
| 1993 | $123.60M | +81.0% | +$55.30M | ||
| 1992 | $68.30M | +78.3% | +$30.00M | ||
| 1991 | $38.30M | +7.6% | +$2.70M | ||
| 1990 | $35.60M | +100.0% | +$17.80M | ||
| 1989 | $17.80M | -7.3% | −$1.40M | ||
| 1988 | $19.20M | +156.0% | +$11.70M | ||
| 1987 | $7.50M | -39.0% | −$4.80M | ||
| 1986 | $12.30M | +151.0% | +$7.40M | ||
| 1985 | $4.90M | — | — |
- 2025$8.11B+5.8%
- 2024$7.66B+2.9%
- 2023$7.45B-12.7%
- 2022$8.53B-17.4%
- 2021$10.32B+30.7%
- 2020$7.90B+85.4%
- 2019$4.26B+10.0%
- 2018$3.87B+18.5%
- 2017$3.27B+14.3%
- 2016$2.86B+14.6%
- 2015$2.49B+6.2%
- 2014$2.35B+30.6%
- 2013$1.80B+10.4%
- 2012$1.63B+10.0%
- 2011$1.48B+17.2%
- 2010$1.26B+13.1%
- 2009$1.12B-11.7%
- 2008$1.27B+18.8%
- 2007$1.07B+191.8%
- 2006$365.30M+24.3%
- 2005$293.77M+15.5%
- 2004$254.44M+37.7%
- 2003$184.77M+18.9%
- 2002$155.45M+354.5%
- 2001$34.20M-82.7%
- 2000$198.16M-20.3%
- 1999$248.60M-33.8%
- 1998$375.80M-7.7%
- 1997$407.00M+43.2%
- 1996$284.20M+14.9%
- 1995$247.30M+37.5%
- 1994$179.80M+45.5%
- 1993$123.60M+81.0%
- 1992$68.30M+78.3%
- 1991$38.30M+7.6%
- 1990$35.60M+100.0%
- 1989$17.80M-7.3%
- 1988$19.20M+156.0%
- 1987$7.50M-39.0%
- 1986$12.30M+151.0%
- 1985$4.90M—
Operating Income values are taken from Thermo Fisher Scientific's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Operating Income at Thermo Fisher Scientific (TMO)
According to Thermo Fisher Scientific's latest reported financial statements, the company's current operating income (TTM) is $8.03B. Operating income is profit from core operations: revenue minus cost of goods sold and operating expenses (SG&A, R&D). It excludes interest, taxes, and non-operating items, so it isolates how profitable the business itself is before financing and tax decisions. Compare with EBITDA and net income.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Thermo Fisher Scientific (TMO) operating income is $8.11B – grew 5.8% year-over-year.
Across 2020–2025 (5 years), Thermo Fisher Scientific operating income produced a CAGR of +0.5% – sustaining 2 straight years of year-over-year growth.
Thermo Fisher Scientific operating income peaked at $10.32B in 2021; the latest annual figure is $8.11B in 2025 (21.4% below peak).
$10.32B stands as the all-time-high annual operating income, posted in 2021, against a low of $4.90M during 1985.
Thermo Fisher Scientific Operating Income by Year
Thermo Fisher Scientific Operating Income 2025: $8.11B
In 2025, Thermo Fisher Scientific reported operating income of $8.11B, grew 5.8% from 2024.
Thermo Fisher Scientific Operating Income 2024: $7.66B
Thermo Fisher Scientific operating income in 2024 was $7.66B, edged up 2.9% from 2023.
Thermo Fisher Scientific Operating Income 2023: $7.45B
2023's operating income for Thermo Fisher Scientific came in at $7.45B, declined 12.7% below 2022.
Thermo Fisher Scientific Operating Income 2022: $8.53B
Thermo Fisher Scientific posted operating income of $8.53B in 2022, declined 17.4% below 2021.
Thermo Fisher Scientific Operating Income 2021: $10.32B
Thermo Fisher Scientific operating income in 2021 was $10.32B.
See more financial history for Thermo Fisher Scientific (TMO).
Sector peers by Operating Income
Healthcare peers of Thermo Fisher Scientific (TMO), ranked by their latest operating income
| $29.70B | |
| $25.60B | |
| $23.49B | |
| $20.09B | |
| $19.90B | |
| $18.96B | |
| $13.74B | |
| $10.68B |
- $29.70B
- $25.60B
- $23.49B
- $20.09B
- $19.90B
- $18.96B
- $13.74B
- $10.68B
Frequently asked questions
Thermo Fisher Scientific (TMO) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation